Carey Danis & Lowe Transvaginal Mesh Lawyers Review Federal Transvaginal Mesh Lawsuits

Click to Enlarge

Click to Enlarge

The team of transvaginal mesh lawyers at Carey Danis & Lowe reviewed the number of transvaginal mesh lawsuits pending in the U.S. District Court for the Southern District of West Virginia. As of late September, there are currently over 32,000 cases filed against six different transvaginal mesh manufacturers, including C. R. Bard, American Medical Systems, Boston Scientific Corp., Ethicon, Coloplast Corp., and Cook Medical.

U.S. District Judge Joseph R. Goodwin is presiding over the six transvaginal mesh multidistrict litigations (MDLs) in the West Virginia federal court.

C. R. Bard faces 4,755 cases, whereas 10,284 lawsuits have been consolidated against American Medical Systems. Plaintiffs have filed 6,267 against Boston Scientific Corp., and 10,108 cases against Ethicon, a Johnson & Johnson subsidiary. Coloplast Corp. faces 1,080 transvaginal mesh lawsuits, and the newest MDL added to the West Virginia federal court, Cook Medical, includes 152 cases.

In the coming months, Carey Danis & Lowe transvaginal mesh lawyers will continue to closely watch the number of new lawsuits being consolidated into these six West Virginia MDLs.

Carey Danis & Lowe is a national law firm based in St. Louis that represents women who claim injury from transvaginal mesh implants. Our team of attorneys works diligently to provide these women with expert legal counsel.

If you or someone you love has been injured by transvaginal mesh, Carey Danis & Lowe encourages you to speak with one of our attorneys today for a free legal evaluation of your mesh case. You can also speak with one of our on-staff nurses concerning transvaginal mesh health problems.

Share your story with Carey Danis & Lowe by calling 800.721.2519, or by submitting a personal injury claim form.

As of late September 2013, there are over 32,000 transvaginal mesh lawsuits pending in a West Virginia federal court. Read more on the Carey Danis & Lowe blog.